FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hait William
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/3/2022 

3. Issuer Name and Ticker or Trading Symbol

JOHNSON & JOHNSON [JNJ]
(Last)        (First)        (Middle)

ONE JOHNSON & JOHNSON PLAZA
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
See Remarks /
(Street)

NEW BRUNSWICK, NJ 08933      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 223158.0000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (Right to Buy) (1)2/11/2017 2/9/2024 Common Stock 59397.0000 $90.4400 D  
Employee Stock Options (Right to Buy) (1)2/10/2018 2/9/2025 Common Stock 51484.0000 $100.0600 D  
Employee Stock Options (Right to Buy) (1)2/9/2019 2/8/2026 Common Stock 54923.0000 $101.8700 D  
Employee Stock Options (Right to Buy) (1)2/13/2020 2/13/2027 Common Stock 41097.0000 $115.6700 D  
Employee Stock Options (Right to Buy) (1)2/12/2021 2/11/2028 Common Stock 37289.0000 $129.5100 D  
Employee Stock Options (Right to Buy) (1)2/11/2022 2/11/2029 Common Stock 37911.0000 $131.9400 D  
Employee Stock Options (Right to Buy) (1)2/10/2023 2/10/2030 Common Stock 49315.0000 $151.4100 D  
Employee Stock Options (Right to Buy) (1)2/8/2024 2/8/2031 Common Stock 33593.0000 $164.6200 D  
Restricted Share Units (2)2/8/2024  (2)Common Stock 3059.0000  (2)D  
Restricted Share Units (2)2/10/2023  (2)Common Stock 3856.0000  (2)D  
Restricted Share Units (2)2/11/2022  (2)Common Stock 7790.0000  (2)D  

Explanation of Responses:
(1) Vested and exercisable on the third anniversary of the date of the grant.
(2) Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:
haitpoa1.txt

Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Hait William
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933


See Remarks

Signatures
Raavi Deol, as attorney-in-fact for William Hait1/13/2022
**Signature of Reporting PersonDate

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Johnson and Johnson Charts.